Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Quart Barry D Create: Alert

All | News | Filings
Date FiledTypeDescription
07/03/2023 4 Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Exercised 5,000 options to buy @ $0
06/08/2023 4 Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 26,236 options to buy @ $15.19, valued at $398.5k
Granted 4,373 options to buy @ $0
01/20/2023 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 850,000 options to buy @ $3.13, valued at $2.7M
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 5,219 shares @ $3.76, valued at $19.6k
Exercised 3,646 restricted stock units @ $0
Exercised 16,122 restricted stock units @ $0
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2022 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 5,219 shares @ $6.07, valued at $31.7k
Exercised 3,646 restricted stock units @ $0
Exercised 16,122 restricted stock units @ $0
01/14/2022 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 5,219 shares @ $8.3, valued at $43.3k
Exercised 3,646 restricted stock units @ $0
Exercised 16,122 restricted stock units @ $0
10/15/2021 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Paid exercise price by delivering 963 shares @ $10.55, valued at $10.2k
Exercised 3,646 restricted stock units @ $0
Granted 390,834 options to buy @ $10.55, valued at $4.1M
Granted 195,417 restricted stock units @ $0
07/15/2021 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 1,529 shares @ $13.8975, valued at $21.2k
Paid exercise price by delivering 963 shares @ $13.48, valued at $13k
Exercised 3,645 restricted stock units @ $0
06/30/2021 4 Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 33,237 options to buy @ $14.33, valued at $476.3k
04/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/15/2020 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 1,158 shares @ $12.121, valued at $14k
Granted 350,000 options to buy @ $15.72, valued at $5.5M
Granted 58,333 restricted stock units @ $0
07/02/2020 4 Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 18,760 options to buy @ $25.48, valued at $478k
12/23/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/30/2019 4 Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.
Txns: Granted 18,760 options to buy @ $15.47, valued at $290.2k
12/18/2018 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 300,000 options to buy @ $24.97, valued at $7.5M
09/14/2018 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Exercised 19,675 options to buy @ $7.2, valued at $141.7k
06/22/2018 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 1,607 shares @ $13.2175, valued at $21.2k
Sold 50,000 shares @ $39.05, valued at $2M
Exercised 50,000 options to buy @ $9.05, valued at $452.5k
03/19/2018 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Sold 100,000 shares @ $29.75, valued at $3M
Exercised 100,000 options to buy @ $7.2, valued at $720k
03/16/2018 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Sold 100,000 shares @ $24.75, valued at $2.5M
Exercised 100,000 options to buy @ $7.2, valued at $720k
12/20/2017 4 Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Acquired 1,684 shares @ $12.6225, valued at $21.3k
Granted 310,000 options to buy @ $17, valued at $5.3M
12/23/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
07/20/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/03/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/10/2013 4 Quart Barry D (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 7,500 options to buy @ $40.32, valued at $302.4k
05/03/2013 4 Quart Barry D (CEO) has filed a Form 4 on AP PHARMA INC /DE/
Txns: Granted 22,500,000 options to buy @ $0.36, valued at $8.1M
06/29/2012 4 Quart Barry D (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP
Txns: Granted 7,500 options to buy @ $40.74, valued at $305.6k
06/20/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
12/29/2011 4 Quart Barry D (President and CEO) has filed a Form 4 on Ardea Biosciences, Inc./DE
Txns: Gifted 5,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy